Vanda Pharmaceuticals | VNDA - Employees Total Number

Stock Price
6.09
Daily Change
-0.03 -0.49%
Monthly
-20.91%
Yearly
37.78%
Q1 Forecast
4.24

Vanda Pharmaceuticals reported 203 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
Akebia Therapeutics 167 37 Dec/2023
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Anika Therapeutics 357 12 Dec/2023
Arrowhead Research 711 102 Dec/2025
AstraZeneca USD 89.9K 6.4K Dec/2023
Bristol-Myers Squibb 34.1K 0 Dec/2024
Eli Lilly 47K 4K Dec/2024
Enanta Pharmaceuticals 145 15 Sep/2023
Esperion Therapeutics 240 41 Dec/2023
Halozyme Therapeutics 350 23 Dec/2024
Heron Therapeutics 126 77 Dec/2023
Insmed 1.27K 359 Dec/2024
J&J 138.1K 6.2K Dec/2024
Lexicon Pharmaceuticals 285 150 Dec/2023
Ligand Pharmaceuticals 68 10 Dec/2024
Merck 75K 3K Dec/2024
Minerva Neurosciences 9 0 Dec/2023
Moderna 5.8K 200 Dec/2024
Novartis 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
PTC Therapeutics 939 49 Dec/2024
Puma Biotechnology 185 7 Dec/2023
Sangamo BioSciences 405 73 Dec/2023
Sanofi 84.59K 3.41K Dec/2024
Takeda 47.46K 1.83K Dec/2025
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023
Veracyte 824 9 Dec/2024